精确调节蛋白质降解的策略
Shipeng He1, Guoqiang Dong2, Chunquan Sheng2
1Institute of Translational Medicine, Shanghai University, 99 Shangda Road, Shanghai 200444, P. R. China.
Accounts of chemical research
|March 25, 2025
概括
使用向蛋白解的仿真体 (PROTACs) 的向蛋白降解 (TPD) 与抑制剂相比具有优势. 智能 PROTAC 设计的创新增强了特异性和控制,解决了精准医学临床翻译的挑战.
科学领域:
- 生物技术是生物技术.
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 使用向蛋白质分解的仿真体 (PROTACs) 的向蛋白质降解 (TPD) 提供了一种降解致病蛋白质的治疗策略.
- 在选择性蛋白质消除过程中,PROTACs利用了全方位素-蛋白酶体系统,扩大了治疗点,超出了传统的抑制范围.
- 传统的PROTAC在临床转化方面面临挑战,包括特异性,溶解性,透性,药理动力学和时空控制.
研究的目的:
- 审查PROTAC智能设计的最新进展,以提高治疗精度.
- 突出提高PROTAC瘤特异性,溶解性,透性和时空控制的策略.
- 讨论基于降解剂的疗法的临床转化所面临的挑战和未来方向.
主要方法:
- 对瘤特异性向和减少非向效应而开发的阿巴胺结合PROTACs.
- 创建药-PROTAC合体,以实现精确的配送和协同效应.
- 使用基于RGD的PROTACs来增强细胞吸收和瘤透.
- 照相控制的PROTACs的设计,用于精确的*in vivo*蛋白质降解的时间调节.
- 开发用于实时监测的同时诊断和治疗的治疗性PROTACs.
主要成果:
- 创新的 PROTAC 设计表明瘤选择性得到改善,系统毒性降低.
- 摄影控制和神经控制的PROTAC提供了前所未有的时间控制和监控能力.
- 先进的 PROTAC 策略解决了传统设计的局限性,增强了药物发现潜力.
结论:
- 智能PROTACs在向蛋白质降解方面取得了重大进展,为克服临床翻译障碍提供了解决方案.
- 这些创新为在瘤学,免疫学和神经退行性疾病中更精确和更有效的降解剂治疗铺平了道路.
- 进一步的研究和开发对于实现这些下一代PROTAC技术的全部临床潜力至关重要.
相关概念视频
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome
8.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.4K
Regulation of Expression at Multiple Steps
857
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
857
mRNA Stability and Gene Expression
5.5K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.5K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Proteins: From Genes to Degradation
11.9K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
11.9K


